1,3-difluorobenzene | CAS:372-18-9

We serve 1,3-difluorobenzene CAS:372-18-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1,3-difluorobenzene

Chemical Name:1,3-difluorobenzene
CAS.NO:372-18-9
Synonyms:1,3-difluorobenzene
m-Difluorobenzene
Molecular Formula:C6H4F2
Molecular Weight:114.09300
 
Physical and Chemical Properties:
Density:1.163
Melting point:-59ºC
Boiling point:83ºC
Flash point:36°F
Index of Refraction:1.438
 
Specification:
Appearance:Colorless to pale yellow clear liquid
Assay:≥99.5%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 1,3-difluorobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,m-Difluorobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,m-Difluorobenzene Use and application,1,3-difluorobenzene technical grade,usp/ep/jp grade.


Related News: Like other countries in Southeast Asia, Indonesia depends heavily on Chinese tourism. On Thursday alone, 10,000 Chinese tourists canceled their trips to Bali, according to one industry association.oleoyl ethanolamide manufacturer In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.methyl 3-[3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-hydroxybenzoate supplier In order to find answers to these questions, our staff in the development department set about conducting a series of experiments.Methyl 4-bromobutyrate vendor Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings.China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.